| View |
|
BRP-013
|
Insulin Glargine
|
Lantus
|
100 I.U./mL (3.64 mg Insulin glargine equivalent to 100 units Human insulin)
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
10mL Type I clear and colorless glass vial
|
-
|
|
|
|
|
|
-
|
05 November 2021
|
17 February 2026
|
| View |
|
BRP-013-01
|
Insulin Glargine
|
Podevta
|
100 I.U./mL (3.64 mg Insulin glargine equivalent to 100 units Human insulin)
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
10 mL Type I Clear and Colorless Glass Vial (Box of
l's)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi Pasteur, Inc.
|
-
|
12 May 2021
|
17 February 2026
|
| View |
|
BRP-014
|
Lantus Solostar
|
Insulin Glargine
|
100 Units (equivalent to 3.64 mg)/mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3 mL Type I colorless glass cartridge assembled in a pre-filled pen (Box of 5's)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
N/A
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi-Aventis Philippines, Inc.
|
Renewal
|
17 February 2023
|
26 February 2028
|
| View |
|
BRP-014-01
|
Insulin Glargine
|
Podevta
|
100 Units (equivalent to 3.64 mg)/mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
3 mL Type I colorless glass cartridge assembled in a pre-filled pen (Box of 5's)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
|
Germany
|
N/A
|
Sanofi-Aventis Philippines, Inc.
|
Renewal
|
22 March 2023
|
26 February 2028
|
| View |
|
BRP-017
|
Biphasic Isophane Human Insulin 30/70 (recombinant DNA)
|
Insulet 30/70
|
100 IU/mL
|
Suspension For Injection (Im/Sc)
|
Prescription Drug (RX)
|
USP Type II Clear glass vial with red flip-off seal x 4mL and 10mL (box of 1's)
|
Antidiabetic
|
Aristopharma Ltd.
|
Bangladesh
|
|
Sahar Internatioal Trading, Inc.
|
Amara Prohealth Solutions Corporation
|
Renewal
|
03 October 2018
|
24 October 2028
|
| View |
|
BRP-018
|
Biphasic Isophane Human Insulin 50/50 (Recombinant DNA)
|
Insulet 50/50
|
100 IU/mL
|
Suspension For Injection (Im/Sc)
|
Prescription Drug (RX)
|
USP Type II Clear glass vial with red flip-off seal x 4mL and 10mL (box of 1's)
|
Antidiabetic
|
Aristopharma Ltd.
|
Bangladesh
|
|
SAHAR INTERNATIONAL TRADING, INC.
|
SAHAR INTERNATIONAL TRADING, INC.
|
Renewal
|
13 November 2018
|
24 October 2028
|
| View |
|
BRP-019
|
Regular Insulin Human (Recombinant DNA)
|
Insulet R
|
100 IU/mL
|
Solution For Injection (Im-Iv-Sc)
|
Prescription Drug (RX)
|
USP Type II Clear glass vial with red flip-off seal x 4mL and 10mL (box of 1's)
|
Antidiabetic
|
Aristopharma Ltd.
|
Bangladesh
|
|
SAHAR INTERNATIONAL TRADING, INC.
|
SAHAR INTERNATIONAL TRADING, INC.
|
Renewal
|
13 November 2018
|
24 October 2028
|
| View |
|
BRP-020
|
Isophane Insulin Human (Recombinant DNA)
|
Insulet N
|
100 IU/mL
|
Suspension For Injection (Im/Sc)
|
Prescription Drug (RX)
|
USP Type II Clear glass vial with red flip-off seal x 4mL and 10mL (box of 1's)
|
Antidiabetic
|
Aristopharma Ltd.
|
Bangladesh
|
|
SAHAR INTERNATIONAL TRADING, INC.
|
SAHAR INTERNATIONAL TRADING, INC.
|
Renewal
|
13 November 2018
|
24 October 2028
|
| View |
|
BRP-021
|
Clostridium Botulinum Toxin Type A
|
Nabota
|
100 Units
|
Lyophilized Powder for Injection (IM/SC)
|
Prescription Drug (RX)
|
USP Type I Glass Vial with Rubber Butyl Stopper and Aluminum seal with white flip-off cap x 10mL (Box of 1's)
|
Muscle Relaxant
|
Daewoong Pharmaceutical Co., Ltd.
|
Korea
|
|
Daewoong Pharma Philippines Inc.
|
Daewoong Pharma Philippines Inc.
|
Renewal (Reconstruction)
|
08 March 2024
|
26 January 2025
|
| View |
|
BRP-030
|
Insulin Glulisine
|
Apidra Solostar
|
3.49 mg/mL (equivalent to 100 Units/mL)
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
Pre-filled Pen in 3 mL Cartridge (Box of 5's)
|
-
|
Sanofi-Aventis Deutschland GmbH
|
Germany
|
|
Sanofi-Aventis Philippines, Inc.
|
Sanofi-Aventis Philippines, Inc.
|
-
|
26 February 2021
|
28 October 2025
|
| View |
|
BRP-034
|
Biphasic Isophane Insulin (Rdna Origin)
|
Wosulin-30/70
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Prescription Drug (RX)
|
10mL glass vial with rubber stopper and brown flip-off seal
|
Intermediate acting insulin
|
Wockhardt Limited
|
India
|
|
Ambica International Corp.
|
GX International Inc.
|
Renewal
|
21 May 2022
|
05 September 2027
|
| View |
|
BRP-034-01
|
Biphasic Isophane Insulin (Rdna Origin)
|
Glysolin 30/70
|
100 I.U./ mL
|
Suspension For Injection (S.C.)
|
Prescription Drug (RX)
|
10 mL glass vial with rubber stopper and brown flip-off seal
|
Intermediate acting insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corporation
|
The Cathay Drug Co., Inc.
|
Automatic Renewal
|
18 July 2022
|
05 September 2027
|
| View |
|
BRP-034-02
|
Biphasic Isophane Insulin (rDNA)
|
Choicesulin
|
100 IU/mL
|
Suspension for Injection (SC)
|
Prescription Drug (Rx)
|
10 mL Glass Vial with Rubber Stopper and Brown Flip-Off Seal Box of 10's
|
Intermediate Acting Insulin
|
Wockhardt Limited
|
India
|
N/A
|
Ambica International Corporation
|
Medchoice Endocrine Group Inc.
|
Renewal
|
05 August 2022
|
05 September 2027
|
| View |
|
BRP-035
|
Regular Insulin Human (Rdna Origin)
|
Wosulin-R
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Prescription Drug (RX)
|
10mL glass vial with rubber stopper and yellow flip-off seal
|
Short acting insulin
|
Wockhardt Limited
|
India
|
|
Ambica International Corp.
|
GX International Inc.
|
Renewal
|
20 May 2022
|
06 September 2027
|
| View |
|
BRP-035-01
|
Regular Insulin Human (Rdna Origin)
|
Glysolin R
|
100 I.U./ mL
|
Solution For Injection (S.C.)
|
Prescription Drug (RX)
|
10 mL glass vial with rubber stopper and yellow flip-off seal
|
Short acting insulin
|
Wockhardt Ltd.
|
India
|
The Cathay YSS Distributor Co., Inc.
|
Ambica International Corporation
|
The Cathay Drug Co., Inc.
|
Automatic Renewal
|
18 July 2022
|
06 September 2027
|
| View |
|
BRP-036
|
Isophane Insulin Human (Rdna Origin)
|
Wosulin-N
|
100 IU/mL
|
Suspension For Injection (Sc)
|
Prescription Drug (RX)
|
10mL glass vial with rubber stopper and green flip-off seal
|
Intermediate acting insulin
|
Wochard Limited
|
India
|
|
Ambica International Corp.
|
GX International Inc.
|
Renewal
|
20 May 2022
|
06 September 2027
|
| View |
|
BRP-036-01
|
Isophane Insulin Human (Rdna Origin)
|
Glysolin N
|
100 I.U./ mL
|
Suspension For Injection (S.C.)
|
Prescription Drug (RX)
|
10 mL glass vial with rubber stopper and green flip-off seal
|
Intermediate acting insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corporation
|
The Cathay Drug Co., Inc.
|
Automatic Renewal
|
18 July 2022
|
06 September 2027
|
| View |
|
BRP-037
|
Insulin Glargine
|
Glaritus
|
100IU/mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3mL USP Type I Clear glass catridge with pen delivery device (Box of 1's)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corp.
|
Ambica International Corp.
|
Renewal
|
28 January 2019
|
03 March 2029
|
| View |
|
BRP-037-01
|
Insulin Glargine
|
Glysolin G
|
100 IU/mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
3mL USP Type I Clear glass catridge with pen delivery device (Box of 1's)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corporation
|
THE CATHAY YSS DISTRIBUTORS CO., INC
|
Renewal
|
16 November 2023
|
03 March 2029
|
| View |
|
BRP-037-03
|
Insulin Glargine
|
Glarsulin
|
100 IU/mL
|
Solution For Injection (Sc)
|
Prescription Drug (RX)
|
3mL USP Type I Clear glass catridge with pen delivery device (Box of 1's)
|
Long-acting Insulin
|
Wockhardt Ltd.
|
India
|
|
Ambica International Corporation
|
Detoxicare Philippines, Inc.
|
Renewal
|
22 November 2023
|
03 March 2029
|